Shared pathophysiology and therapeutic repurposing in Alzheimer's disease and type 2 diabetes: a critical review of convergent mechanisms and clinical challenges

This publication has 167 references indexed in Scilit:

• Recent advances in the treatment of type 2 diabetes mellitus using new drug therapies
  The Kaohsiung Journal of Medical Sciences, 2024
• 2023 Alzheimer's disease facts and figures
  Alzheimer's & Dementia, 2023
• The potential role of Keap1-Nrf2 pathway in the pathogenesis of Alzheimer’s disease, type 2 diabetes, and type 2 diabetes-related Alzheimer’s disease
  Metabolic Brain Disease, 2021
• Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status
  Alzheimer's & Dementia, 2020
• An update on potential links between type 2 diabetes mellitus and Alzheimer’s disease
  Molecular Biology Reports, 2020
• Sulfonyl(thio)urea derivative induction of insulin secretion is mediated by potassium, calcium, and sodium channel signal transduction
  Journal of Cellular Physiology, 2018
• Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes
  Clinical and Experimental Medicine, 2018
• Mechanism of Generation of Oxidative Stress and Pathophysiology of Type 2 Diabetes Mellitus: How Are They Interlinked?
  Journal of Cellular Biochemistry, 2017
• Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice
  Journal of Neural Transmission, 2014
• The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
  Current Diabetes Reports, 2013